Avience Biomedicals Limited IPO (AVIENCE)
Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.
Brokerage-free equity & mutual fund investments
Trade with Zerodha's Kite platform and tools.
- Zero brokerage on equity delivery
- ₹20 flat for intraday, F&O, currency and commodity*
- Free direct mutual fund investing
Flat ₹20 per order, every segment
Trade stocks, derivatives and more on 5paisa's platform.
- ₹20 flat for delivery, intraday and F&O
- Free account opening
- Listed on NSE and BSE
Frequently asked questions
What is the price band for the Avience Biomedicals Limited IPO?
The Avience Biomedicals Limited IPO price band is Rs.196 to Rs.208 per share.
When does the Avience Biomedicals Limited IPO open and close?
Bidding opens 18 June 2026 and closes 22 June 2026.
Is the Avience Biomedicals Limited IPO a mainboard or SME issue?
Avience Biomedicals Limited is an SME IPO, listing on NSE Emerge.
When did the Avience Biomedicals Limited IPO list?
Avience Biomedicals Limited listed on 25 June 2026.
Does this page show the grey market premium (GMP) for Avience Biomedicals Limited?
No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.
Is investing in the Avience Biomedicals Limited IPO recommended by BrokerLens?
No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.